Straylight levels could be linked to corneal healing

Article

Straylight values improve over time and can be linked to the progression of corneal healing, according to a paper.

Straylight values improve over time and can be linked to the progression of corneal healing, according to a paper.

The prospective study, led by Dr Yan Wang, Tianjin Eye Hospital & Eye Institute, Ophthalmology and Visual Science Key Laboratory, Tianjin Medical University, Tianjin, China, involved 128 consecutive eyes from 66 patients. Thin-flap LASIK with a femtosecond laser was performed in 61 eyes of 31 patients and think-flap LASIK with mechanical microkeratome was performed in 67 eyes of 35 patients.

All eyes were ablated using the VIXS S4 excimer laser system after flap creation. Straylight values were measured with the C-Quant straylight meter preoperatively, 1 day, 1 week, 1 month, 6 months and 1 year postoperatively.

The mean preoperative straylight values were 0.93 ± 0.11 but the postoperative values were 1.00 ± 0.11, 0.98 ± 0.10, and 0.99 ± 0.12 at 1 day, 1 week, and 1 month, respectively in the femtosecond thin-flap LASIK group. These values decreased and returned to the preoperative levels and 6 months and 1 year postoperatively.

The postoperative-preoperative increases in straylight were more reduced in the femtosecond laser group compared to the mechanical microkeratome group at 0.05 ± 0.13 vs 0.10 ± 0.13 at 1 month postoperatively. There was a significant negative correlation between preoperative straylight values and postoperative-preoperative increases.

Straylight levels return to preoperative levels and the results indicate this could be related to the progression of corneal healing.

Please visit the Journal of Refractive Surgery to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.